Hôpital Lariboisière — Paris

Public research footprint of Hôpital Lariboisière, compiled from the ClinicalTrials.gov public registry.

262

Registered studies

Active

Recruiting now

124

Completed

Stopped or withdrawn

Most-studied conditions

Diabetes Mellitus · Mild Cognitive Impairment Due to Alzheimer's Disease · Heart Failure With Reduced Ejection Fraction · Alzheimer's Disease Psychosis

Recently updated registry entries

NCT07317102 — Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B) (Recruiting)
NCT07039942 — French Prospective Multicentric Study in Real World (Active Not Recruiting)
NCT05049798 — A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Hôpital Lariboisière?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.